Speaker Profile
Director, Clinical Genetics, Agena Biosystems
Biography
Glenn Sawyer has worked in the biotech space for 30 years spanning a diverse array of roles, from RD bench scientist, to Field Applications Scientist, Sales, Marketing and Leadership. At Agena Bioscience, he is currently the commercial team lead for the rapid development, launch and implementation of products serving the Pharmacogenomics (PGx), hereditary genetics and infectious disease markets.
Talk
Guideline-Driven PGx Testing: A Targeted Approach
Design, performance and implementation of targeted panel design containing AMP Tier 1 and Tier 2 consensus recommendations for standardization of alleles for clinical pharmacogenomic genotyping assays. Attendees will gain insights into these evidence-based guidelines and the implementation of standardized PGx testing within the laboratory.
Pharmacogenomics Showcase:
Agena Biosystems
Agena Bioscience® makes clinical genomics accessible to high-complexity clinical labs, enabling and simplifying genetic test deployment. Our foundational platform, the MassARRAY® System, is a highly sensitive, cost-effective genetic testing system used globally in diverse fields such as pharmacogenetics, hereditary genetics, infectious disease, and cancer profiling.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 PGx Showcase will provide 15 minute speaking opportunities for selected companies working with the latest technologies in precision medicine to highlight their contributions to the field.
